APS Management Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$552K Sell
2,029
-749
-27% -$195K 0.4% 44
2026
Q2
$689K Buy
2,778
+134
+5% +$28.9K 0.53% 43
2026
Q1
$531K Sell
2,644
-199
-7% -$41.2K 0.45% 50
2025
Q4
$588K Sell
2,843
-535
-16% -$107K 0.5% 45
2025
Q3
$606K Buy
+3,378
New +$575K 0.54% 47

Other funds holding FBT

APS Management Group's FBT Position: Q3 2026 in Review

APS Management Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 27% in Q3 2026, selling an estimated $195K and leaving 2,029 shares worth $552K. The position accounts for 0.4% of the portfolio, ranked #44.

APS Management Group first reported a position in FBT in Q3 2025 and has held it in 5 quarters since. The position peaked at $689K in Q2 2026. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • APS Management Group held 2,029 shares of First Trust NYSE Arca Biotechnology Index Fund worth $552K as of Q3 2026.
  • APS Management Group sold 749 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $195K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.4% of APS Management Group's portfolio in Q3 2026, its #44 holding.
  • APS Management Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2025 and has held it in 5 quarters since.
  • APS Management Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $689K in Q2 2026.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on APS Management Group's 13F filing for Q3 2026, filed 14 Oct 2026.